skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I understand that Softbank's WeWork troubles might require it to unload some of its Guardant Health stake, but: shouldn't this be priced-in (to Guardant's share price) by now? Or are the details of Softbank's response to WeWork so all-over-the-place that nobody can guesstimate the collateral damage? Or has Guardant's decline put it in an end-of-year tax-loss vortext, such that it doesn't matter, now, what Softbank does?
Read Answer Asked by John on October 21, 2019
Q: I am looking at adding Akumin for some exposure to the health care field and like that they are Canadian but operate in the U.S. Could you please give me your thoughts on this company and its potential growth over the next 3-5 years.
Also, can you please tell me the difference between AKU;CA and AKU.U;CA, and which you would recommend buying.

thanks
Read Answer Asked by Paula on October 17, 2019
Q: Listed as AUPH on Nasdaq. On 9/13,it establishes At-the Market Facility to sell shares up to US$40m from time to time through Jefferies.Since then the price(US$6.59) had dropped sharply to US$3.88(close on Oct 14) Results of Phase 3 on its lead drug expected by year end.My Can $8.33 p/p had dropped 34.7% to a 1% position.Please comment on the company.Also should I buy,hold or sell?Txs for u usual great services & views
Read Answer Asked by Peter on October 16, 2019
Q: I am curiuos about your take on Pharmagreen Biotech
Read Answer Asked by Jim on October 15, 2019
Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?
Read Answer Asked by jacques on October 09, 2019